Rituximab and New Regimens for Indolent Lymphoma: A Brief Update From 2012 ASCO Annual Meeting

Cancer Cell International - United Kingdom
doi 10.1186/1475-2867-12-38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy